The associations between cigarette smoking, plasma leucocyte elastase concentration, peripheral leucocyte count and FEV, were examined in 148 men, 72 of whom were current cigarette smokers, 40 of whom were ex-smokers, and 36 who had never smoked. All men were part of a long-term survey. Smokers 
of whom were current cigarette smokers, 40 of whom were ex-smokers, and 36 who had never smoked. All men were part of a long-term survey. Smokers Differences between the blood leucocyte counts and plasma elastase concentrations were determined by the Mann-Whitney U test (the non-parametric equivalent of the two sample t test). Correlations between different variables were examined using Spearman's rank correlation coefficient.
Results

EFFECT OF SMOKING HABIT ON PLASMA ELASTASE CONCENTRATIONS AND LEUCOCYTE COUNTS
Mean plasma elastase concentration in smokers was significantly higher than in ex-smokers (p < 0 001) or non-smokers (p < 0 05), with some smokers showing greatly increased concentrations (table, figure) . There was no significant difference in elastase concentration between non-smokers and ex-smokers (p = 0-056). As expected, the average number of blood leucocytes was also significantly higher in smokers than in non-smokers (table) (p < 0-001) or ex-smokers (p < 0 001), again with no significant differences between non-smokers and ex-smokers. Mixed expired carbon monoxide at the time of blood sampling was increased in smokers, averaging 7 6, 12 8, and 16 0 ppm in smokers who consumed < 15, 16-25, and >25 cigarettes/day, respectively. In the smokers there was no correlation between the reported daily number of cigarettes smoked or mixed expired carbon monoxide and the increase in either the plasma elastase concentration or leucocyte count. There was no significant correlation in any of the three groups between the plasma elastase concentrations and leucocyte counts (smokers: r = 0 19; ex-smokers: r = 0 18; non-smokers: r = 0-09).
SPIROMETRY
At the time of study, FEV, was significantly lower in smokers (table) than in non-smokers (p < 0-001) and ex-smokers (p = 0 001). Over the preceding 10 years, smokers had shown a significantly greater decline in height-Plasma leucocyte elastase concentrations in individual non-smokers, ex-smokers, and current smokers. Note that the two highest values in smokers are off-scale and were 367 and 451 itg/l, respectively. 
Discussion
In this study we found that on average cigarette smokers had a significantly higher circulating concentration of leucocyte elastase than either non-smokers or ex-smokers. This increase could not be accounted for by the presence of a coincident infectious disease, because serum C-reactive protein was normal in most subjects. We took care to handle the blood specimens so as to avoid in vitro release of elastase from white cells; others have shown that plasma elastase values remain stable in vitro over one hour, provided coagulation is avoided.'7 Furthermore, we found no correlation between the plasma elastase concentration and peripheral leucocyte count in smokers, even although, as previously shown by several groups,23 their leucocyte count was also raised. We aimed to study typical diurnal values in our subjects and made no attempt to control their preceding smoking history, although details of this were obtained for the hours before venesection.
Although diurnal variation in plasma elastase has not been shown, rises in plasma elastase in an individual smoker have been shown after a period of particularly intense smoking,'2 which is also associated with an acute rise in blood neutrophil counts. In our study, however, there was no relation between mixed expired carbon monoxide, a marker of the recent smoking history, and plasma elastase concentrations. None of the smokers with expired carbon monoxide of > 20 ppm had elastase concentrations above 160 jg/l; the 15 
